Michael J Wannemuehler Selected Research

Michael J Wannemuehler Research Topics

Disease

12	Inflammation (Inflammations) 06/2023 - 01/2011
6	Neoplasms (Cancer) 01/2022 - 01/2018
5	Bites and Stings (Sting) 04/2024 - 01/2019
5	Colitis 04/2024 - 10/2011
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2018
4	Infections 11/2018 - 04/2007
4	Human Influenza (Influenza) 01/2018 - 11/2014
3	Weight Loss (Weight Reduction) 01/2020 - 02/2010
2	Plague (Bubonic Plague) 12/2019 - 03/2011
1	Ulcerative Colitis 04/2024
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Disease Progression 05/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2019
1	Fever (Fevers) 01/2017
1	Orthomyxoviridae Infections 01/2017
1	Influenza in Birds (Avian Flu) 09/2014
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 11/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2011
1	Communicable Diseases (Infectious Diseases) 03/2011
1	Paratuberculosis (Johne's Disease) 01/2011
1	Tuberculosis (Tuberculoses) 04/2009
1	Malaria 04/2009
1	Necrosis 07/2007
1	Opportunistic Infections (Opportunistic Infection) 04/2007

Drug/Important Bio-Agent (IBA)

10	VaccinesIBA 06/2023 - 03/2011
8	AntigensIBA 12/2021 - 10/2011
7	CytokinesIBA 04/2024 - 04/2015
7	NanovaccinesIBA 01/2021 - 07/2014
4	MicellesIBA 04/2024 - 03/2019
3	Vaccine AdjuvantsIBA 03/2019 - 04/2009
2	ChemokinesIBA 06/2023 - 11/2015
2	Biocompatible Materials (Biomaterials)IBA 06/2023 - 12/2021
2	AntibodiesIBA 01/2021 - 11/2015
2	Glycoproteins (Glycoprotein)IBA 05/2019 - 11/2014
2	incomplete Freund's adjuvantIBA 01/2019 - 02/2013
2	Hemagglutinins (Hemagglutinin)IBA 01/2015 - 11/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012 - 07/2007
1	InterferonsIBA 04/2024
1	RU.521IBA 04/2024
1	Hyaluronic Acid (Hyaluronan)IBA 04/2024
1	stearic acid (magnesium stearate)FDA LinkGeneric 04/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 04/2024
1	LipopolysaccharidesIBA 06/2023
1	IonomycinIBA 06/2023
1	Toll-Like Receptor AgonistsIBA 03/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2023
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022
1	Drinking WaterIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Dextrans (Dextran)FDA Link 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Recombinant Fusion ProteinsIBA 12/2019
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 12/2019
1	Mucin-4IBA 05/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Poloxamer (Poloxamer 407)IBA 01/2019
1	Cancer VaccinesIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2016
1	Fatty Acid-Binding ProteinsIBA 11/2015
1	Proteins (Proteins, Gene)FDA Link 11/2015
1	Immunoglobulins (Immunoglobulin)IBA 11/2015
1	Bacterial AntigensIBA 11/2015
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 11/2015
1	Subunit VaccinesIBA 11/2014
1	aluminum sulfate (alum)IBA 02/2013
1	MetallothioneinIBA 08/2012
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 08/2012
1	IronIBA 08/2012
1	fatty acid-binding protein 6IBA 08/2012
1	Cell Adhesion MoleculesIBA 08/2012
1	Interleukin-8 (Interleukin 8)IBA 08/2012
1	Carcinoembryonic AntigenIBA 08/2012
1	S100 Calcium Binding Protein GIBA 08/2012
1	Aldehyde Dehydrogenase 1 FamilyIBA 08/2012
1	Metalloproteases (Metalloproteinases)IBA 08/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2012
1	claudin 8IBA 08/2012
1	NeurotensinIBA 08/2012
1	Dextran SulfateIBA 01/2011
1	Peroxidase (Myeloperoxidase)IBA 02/2010
1	Interleukin-12 (IL 12)IBA 07/2007
1	Interleukin-6 (Interleukin 6)IBA 07/2007
1	Interferon-gamma (Interferon, gamma)IBA 07/2007
1	Bacterial LysatesIBA 07/2007
1	PolyaminesIBA 04/2007
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2007

Therapy/Procedure

5	Therapeutics 01/2022 - 04/2007
4	Immunotherapy 01/2022 - 01/2018
1	Oral Administration 11/2015